Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Current Leases (2020 - 2025)

Outset Medical (OM) has disclosed Current Leases for 6 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Current Leases fell 3.34% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 3.34% year-over-year, with the annual reading at $1.7 million for FY2025, 3.34% down from the prior year.
  • Current Leases for Q4 2025 was $1.7 million at Outset Medical, down from $1.9 million in the prior quarter.
  • The five-year high for Current Leases was $1.9 million in Q3 2025, with the low at $984000.0 in Q1 2021.
  • Average Current Leases over 5 years is $1.5 million, with a median of $1.5 million recorded in 2023.
  • The sharpest move saw Current Leases skyrocketed 41.82% in 2021, then dropped 3.34% in 2025.
  • Over 5 years, Current Leases stood at $1.2 million in 2021, then grew by 14.51% to $1.3 million in 2022, then rose by 20.86% to $1.6 million in 2023, then increased by 12.93% to $1.8 million in 2024, then decreased by 3.34% to $1.7 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.7 million, $1.9 million, and $1.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.